Week in Review: January 27–31

Stimulus-triggered pluripotency; antioxidants speed lung tumor growth; the importance of seminal vesicles; how a plant pathogen jumps hosts

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

HARUKO OBOKATAResearchers from Japan presented a new approach for transforming differentiated cells into a pluripotent state, based on exposure to environmental stimuli as opposed to genetic manipulation, in two papers published in Nature this week (January 29).

“It’s pretty unexpected,” Rudolph Jaenisch of the Whitehead Institute in Cambridge, Massachusetts, who was not involved in the study, told The Scientist. “There’s no genetic manipulation, just some culture conditions, stress, to induce these changes. I think that’s quite remarkable.”

WIKIPEDIA, RAGESOSSIn a mouse model of lung cancer, scientists have shown how two antioxidants, vitamin E and N-acetylcysteine, can fuel tumor growth, helping to explain the results of an array of human clinical trials. The work was published in Science Translational Medicine this week (January 29). “If we give extra antioxidants in the diet, we’re helping the tumor to reduce radicals that would otherwise block its growth,” explained Martin Bergo from the University of Gothenburg, who led the research.

PNAS, DOI/10.1073/PNAS.1305609111While male mice lacking seminal vesicles have reduced fertility, they can still father offspring, although their sons exhibit signs of insulin resistance and other symptoms of metabolic syndrome. That’s the conclusion of a January 27 PNAS study led by investigators from the University of Adelaide in Australia.

Cornell University’s Susan Suarez, who was not involved in the work, noted that these results in mice could have implications for human in vitro fertilization (IVF). Since the first IVF procedure was performed, she said, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies